Idiopathic pulmonary fibrosis trials in Spain

In Spain 19 Also abroad 111

19 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Where
Barcelona, L'hospitalet De Llobregat, Madrid, Málaga, Valencia
Age
18 years and over
People
139 worldwide
Run by
AstraZeneca AB
See details and how to join2025-525016-41-00 · EU 2025-525016-41-00
Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Where
Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Santander, Santiago de Compostela, Valencia
Age
40 years and over
People
324 worldwide
Run by
Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00
Phase 2Not yet taking people in Spain
A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment
Where
Barcelona, L Hospitalet Del Llobregat, Madrid, Seville
Age
40 years and over
People
70 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07926321 · EU 2026-527098-13-00
Phase 2Taking people
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Where
Barcelona, Granada, Madrid, Málaga, Santander
Age
18 years and over
People
340 worldwide
Run by
Avalyn Pharma Inc.
See details and how to joinNCT06951217
Phase 2Not yet taking people in Spain
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
Where
Barcelona, Girona, Madrid, Málaga, Pamplona, Santander, Santiago de Compostela, Valencia
Age
18 years and over
People
112 worldwide
Run by
Agomab Spain S.L.U.
See details and how to join2026-526404-71-00 · EU 2026-526404-71-00
Phase 3Not yet taking people in Spain
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Where
Barcelona, Coslada, L'Hospitalet De Llobregat, Madrid, Málaga, Oviedo, Santander, Santiago de Compostela
Age
18 years and over
People
2,380 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00
Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Where
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Valencia
Age
40 years and over
People
359 worldwide
Run by
AstraZeneca
See details and how to joinNCT07652658
Phase 3Taking people
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Where
Alicante, Barcelona, Madrid, Málaga, Palma, Pamplona, Pozuelo de Alarcón, Santander, Sevilla, Valencia
Age
40 years and over
People
1,100 worldwide
Run by
PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00
No phaseTaking people
Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial
Where
Granollers
Age
18 years and over
People
92
Run by
Hospital de Granollers
See details and how to joinNCT07482917
Phase 3Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Where
Barcelona, Granada, L'Hospitalet de Llobregat, Madrid, Málaga, Murcia, Oviedo, Palma de Mallorca, Santander, Santiago de Compostela
Age
40 years and over
People
1,850 worldwide
Run by
United Therapeutics
See details and how to joinNCT04905693
Phase 2Taking people
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Where
Barcelona, Granollers, L'hospitalet De Llobregat, Madrid, Málaga, Murcia, Pamplona, Santander, Santiago de Compostela
Age
40 years and over
People
240 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07516951 · EU 2024-514246-37-00
Phase 2Taking people
An Open-Label Extension Study of Subjects who Received an Avalyn Inhaled Antifibrotic Agent
Where
Granada, L'hospitalet De Llobregat, Madrid, Málaga, Santander
Age
18 years and over
People
128 worldwide
Run by
Avalyn Pharma Inc.
See details and how to join2024-518289-28-00 · EU 2024-518289-28-00
Phase 2Taking people
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
Where
Badalona, Barcelona, Granollers, L'hospitalet De Llobregat, Madrid, Málaga, Sabadell, Santander
Age
40 years and over
People
160 worldwide
Run by
Avalyn Pharma Inc.
See details and how to joinNCT07194382 · EU 2025-523431-19-00
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
Where
Barcelona, Coslada (Madrid), Girona, Madrid, Oviedo, Santander, Santiago de Compostela
Age
18 years and over
People
239 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 · EU 2023-503697-21-01
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
Where
Barcelona, L'hospitalet De Llobregat, Madrid, Majadahonda, Málaga, Oviedo, Santander, Santiago de Compostela
Age
18 years and over
People
249 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 · EU 2023-503699-25-00
Phase 2Taking people
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Where
Barcelona, Madrid, Pozuelo de Alarcón, Santander, Santiago de Compostela, Valencia
Age
40 years and over
People
165 worldwide
Run by
AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00
No phaseTaking people
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Where
Madrid
Age
18 years to 80 years
People
500 worldwide
Run by
University of Massachusetts, Worcester
See details and how to joinNCT06855329
No phaseTaking people
Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease
Where
Granollers
Age
18 years and over
People
100
Run by
Hospital de Granollers
See details and how to joinNCT07723872
Phase 3Taking people
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Where
Barcelona, L'hospitalet De Llobregat, Madrid, Málaga, Murcia, Santander, Santiago de Compostela
Age
18 years and over
People
698 worldwide
Run by
United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00